CTNM

SEC source: 0001437749-26-005889 · rdgdoc.xml · nonDerivative · entry 3

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 159,876

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-005892 · rdgdoc.xml · derivative · entry 5

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 123,617

Underlying: Class A Common Stock · 4,400 shares

Expires 2028-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F4 · derivative.exercise_date: The stock options are fully vested and exercisable.

SEC source: 0001437749-26-005892 · rdgdoc.xml · nonDerivative · entry 2

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,954

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.15, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-26-005892 · rdgdoc.xml · nonDerivative · entry 1

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 19,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-005889 · rdgdoc.xml · derivative · entry 6

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 71,130

Underlying: Class A Common Stock · 4,300 shares

Expires 2030-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F4 · derivative.exercise_date: The stock options are fully vested and exercisable.

SEC source: 0001437749-26-005889 · rdgdoc.xml · nonDerivative · entry 2

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,052

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.00 to $16.15, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-26-005889 · rdgdoc.xml · nonDerivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,352

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-004912 · rdgdoc.xml · derivative · entry 4

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,430

Underlying: Class A Common Stock · 100 shares

Expires 2030-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · derivative.exercise_date: The stock options are fully vested and exercisable.

SEC source: 0001437749-26-004912 · rdgdoc.xml · nonDerivative · entry 2

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,052

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-004912 · rdgdoc.xml · nonDerivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-004126 · rdgdoc.xml · derivative · entry 3

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 128,017

Underlying: Class A Common Stock · 400 shares

Expires 2028-11-13

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F3 · derivative.exercise_date: The stock options are fully vested and exercisable.

SEC source: 0001437749-26-004126 · rdgdoc.xml · nonDerivative · entry 2

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 14,954

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-004126 · rdgdoc.xml · nonDerivative · entry 1

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 15,354

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · balance_after: Includes 1,246 shares purchased through Issuer's Employee Stock Purchase Plan on November 15, 2024 and 2,096 shares purchased through Issuer's Employee Stock Purchase Plan on May 15, 2025.

SEC source: 0001437749-26-004122 · rdgdoc.xml · derivative · entry 4

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 75,530

Underlying: Class A Common Stock · 400 shares

Expires 2030-02-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · derivative.exercise_date: The stock options are fully vested and exercisable.

SEC source: 0001437749-26-004122 · rdgdoc.xml · nonDerivative · entry 2

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,052

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-004122 · rdgdoc.xml · nonDerivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,452

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-003212 · rdgdoc.xml · nonDerivative · entry 2

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 156,052

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.12 to $15.45, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-26-003212 · rdgdoc.xml · nonDerivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 157,222

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.12 to $15.08, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-26-002575 · rdgdoc.xml · derivative · entry 5

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Class A Common Stock · 160,000 shares

Expires 2036-01-29

F5 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.

SEC source: 0001437749-26-002577 · rdgdoc.xml · derivative · entry 1

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 445,000

Underlying: Class A Common Stock · 445,000 shares

Expires 2036-01-29

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.

SEC source: 0001437749-26-002576 · rdgdoc.xml · derivative · entry 2

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 6,500

Underlying: Class A Common Stock · 6,500 shares

Expires 2036-01-29

F2 · derivative.exercise_date: Options granted under the Plan in connection with Reporting Person's spouse's continuous service at the Company. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's spouse's continuous service.

SEC source: 0001437749-26-002576 · rdgdoc.xml · derivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 160,000

Underlying: Class A Common Stock · 160,000 shares

Expires 2036-01-29

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"). The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.

SEC source: 0001437749-26-002579 · rdgdoc.xml · derivative · entry 1

Healy John Stephen · CIK 0001908071 · General Counsel and Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,411

Underlying: Class A Common Stock · 206,411 shares

Expires 2036-01-29

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.

SEC source: 0001437749-26-002578 · rdgdoc.xml · derivative · entry 1

Slover Peter T · CIK 0001468012 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 192,000

Underlying: Class A Common Stock · 192,000 shares

Expires 2036-01-29

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. The options shares vest in equal monthly installments over 48 months, subject to the Reporting Person's continuous service.

SEC source: 0001437749-26-002575 · rdgdoc.xml · derivative · entry 4

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 252,778

Underlying: Class A Common Stock · 3,611 shares

Expires 2035-04-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F4 · derivative.exercise_date: One-half of the option shares vested on October 28, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-26-002575 · rdgdoc.xml · nonDerivative · entry 3

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $14.45 to $14.53, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-26-002575 · rdgdoc.xml · nonDerivative · entry 2

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 811

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.44 to $14.39, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-26-002575 · rdgdoc.xml · nonDerivative · entry 1

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-26-000616 · rdgdoc.xml · nonDerivative · entry 2

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,222

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.34, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-26-000616 · rdgdoc.xml · nonDerivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 160,722

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.000 to $10.955, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-25-038938 · rdgdoc.xml · derivative · entry 3

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 256,389

Underlying: Class A Common Stock · 3,611 shares

Expires 2035-04-27

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F3 · derivative.exercise_date: One-half of the option shares vested on October 28, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-038938 · rdgdoc.xml · nonDerivative · entry 2

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 0

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.39, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-25-038938 · rdgdoc.xml · nonDerivative · entry 1

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 3,611

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These transactions were effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

SEC source: 0001437749-25-038936 · rdgdoc.xml · nonDerivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 164,392

F1 · kind: This transaction was effected pursuant to a 10b5-1 trading plan adopted by the reporting person on September 23, 2025.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.00 to $12.38, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote to this Form 4.

SEC source: 0001437749-25-021372 · rdgdoc.xml · derivative · entry 1

Schimmelpennink Evert B. · CIK 0001713795 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,750

Underlying: Class A Common Stock · 14,750 shares

Expires 2035-06-25

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-021373 · rdgdoc.xml · derivative · entry 1

Boyce Sarah · CIK 0001629383 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,750

Underlying: Class A Common Stock · 14,750 shares

Expires 2035-06-25

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-021371 · rdgdoc.xml · derivative · entry 1

Brady Todd R. · CIK 0001767644 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,750

Underlying: Class A Common Stock · 14,750 shares

Expires 2035-06-25

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-021369 · rdgdoc.xml · derivative · entry 1

Ignelzi Troy A. · CIK 0001579829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,750

Underlying: Class A Common Stock · 14,750 shares

Expires 2035-06-25

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-021367 · rdgdoc.xml · derivative · entry 1

Lyons-Williams Lori · CIK 0001693564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,750

Underlying: Class A Common Stock · 14,750 shares

Expires 2035-06-25

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-021366 · rdgdoc.xml · derivative · entry 1

Ware Olivia C · CIK 0001663771 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,750

Underlying: Class A Common Stock · 14,750 shares

Expires 2035-06-25

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-021365 · rdgdoc.xml · derivative · entry 1

Miralles Gines Diego · CIK 0001773413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,750

Underlying: Class A Common Stock · 14,750 shares

Expires 2035-06-25

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the Issuer's Non-Employee Director Compensation Program, as amended, which states that upon the conclusion of each regular annual meeting of the Company's stockholders, each non-employee director who continues to serve as a member of the Company's Board of Directors thereafter will automatically be granted a stock option under the Plan for 14,750 shares of the Company's Class A Common Stock. Option will vest in full on the earlier of (i) June 26, 2026, the one-year anniversary of the date of grant, or (ii) the next regular annual meeting of stockholders, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-013340 · rdgdoc.xml · derivative · entry 2

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 26,000

Underlying: Class A Common Stock · 26,000 shares

Expires 2035-04-27

F2 · derivative.exercise_date: Options granted outside of the Plan, pursuant to the inducement grant exception under Nasdaq Marketplace Rule 5635(c)(4). This grant is subject to a performance-based vesting condition to be satisfied upon the achievement of a particular clinical milestone, based on such performance condition being satisfied within two years of the grant date and subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-013340 · rdgdoc.xml · derivative · entry 1

Watkins Tim · CIK 0002065965 · CMO & Head of Development

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 260,000

Underlying: Class A Common Stock · 260,000 shares

Expires 2035-04-27

F1 · derivative.exercise_date: Options granted outside of the Issuer's 2024 Equity Incentive Plan (the "Plan"), pursuant to the inducement grant exception under Nasdaq Marketplace Rule 5635(c)(4). One-half of the option shares vest on October 28, 2025, and the remainder vests in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-008003 · rdgdoc.xml · derivative · entry 1

Miralles Gines Diego · CIK 0001773413 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,500

Underlying: Class A Common Stock · 29,500 shares

Expires 2035-03-13

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan, pursuant to the Issuer's Non-Employee Director Compensation Program, as amended. One-third of the option shares vest on March 14, 2026, and the remainder vests in 24 equal monthly installments thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-002429 · rdgdoc.xml · derivative · entry 1

Huhn Stephen L. · CIK 0001863904 · CMO & Sr VP, Clinical Dev.

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2035-01-30

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-002424 · rdgdoc.xml · derivative · entry 1

Stengone Carmine N. · CIK 0001861519 · Director · CEO and President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 300,000

Underlying: Class A Common Stock · 300,000 shares

Expires 2035-01-30

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-002431 · rdgdoc.xml · derivative · entry 2

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · By Spouse

Disclosed balance after: 3,700

Underlying: Class A Common Stock · 3,700 shares

Expires 2035-01-30

F2 · derivative.exercise_date: Options granted under the Plan in connection with Reporting Person's spouse's continuous service at the Company. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's spouse's continuous service.

SEC source: 0001437749-25-002431 · rdgdoc.xml · derivative · entry 1

Lorrain Daniel S. · CIK 0001861550 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2035-01-30

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan (the "Plan"). 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-002436 · rdgdoc.xml · derivative · entry 1

Healy John Stephen · CIK 0001908071 · General Counsel and Corp Sec

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,589

Underlying: Class A Common Stock · 63,589 shares

Expires 2035-01-30

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026, and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.

SEC source: 0001437749-25-002435 · rdgdoc.xml · derivative · entry 1

Slover Peter T · CIK 0001468012 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 110,000

Underlying: Class A Common Stock · 110,000 shares

Expires 2035-01-30

F1 · derivative.exercise_date: Options granted under the Issuer's 2024 Equity Incentive Plan. 25% of the option shares vest on January 1, 2026 and the remainder vests in equal monthly installments over the next 36 months thereafter, subject to the Reporting Person's continuous service.